Edition:
United Kingdom

Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

147.19USD
3:57pm GMT
Change (% chg)

$-0.54 (-0.37%)
Prev Close
$147.73
Open
$147.50
Day's High
$148.72
Day's Low
$146.72
Volume
670,306
Avg. Vol
2,031,763
52-wk High
$148.72
52-wk Low
$118.62

Select another date:

Fri, Nov 16 2018

Photo

New jury fails to reach verdict in J&J South Carolina talc cancer trial

A second South Carolina jury on Thursday failed to reach a verdict in the retrial of a case by a woman whose family said her long-term use of Johnson & Johnson's baby powder led to her death from asbestos-related cancer.

New jury fails to reach verdict in J&J South Carolina talc cancer trial

A second South Carolina jury on Thursday failed to reach a verdict in the retrial of a case by a woman whose family said her long-term use of Johnson & Johnson's baby powder led to her death from asbestos-related cancer.

New jury fails to reach verdict in J&J S. Carolina talc cancer trial

Nov 15 A second South Carolina jury on Thursday failed to reach a verdict in the retrial of a case by a woman whose family said her long-term use of Johnson & Johnson's baby powder led to her death from asbestos-related cancer.

Jury clears J&J of liability in California talc cancer case

A California jury on Wednesday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said.

Jury clears J&J of liability in California talc cancer case

A California jury on Wednesday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said.

Jury clears J&J of liability in California talc cancer case

Nov 14 A California jury on Wednesday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said.

Deals of the day-Mergers and acquisitions

Oct 23 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

J&J makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z

TOKYO U.S. healthcare conglomerate Johnson & Johnson said on Tuesday it will buy all outstanding shares of Japanese skincare firm Ci:z Holdings Co Ltd that it does not already own for 230 billion yen ($2.05 billion) in cash. | Video

Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z

TOKYO U.S. healthcare conglomerate Johnson & Johnson said on Tuesday it will buy all outstanding shares of Japanese skincare firm Ci:z Holdings Co Ltd that it does not already own for 230 billion yen ($2.05 billion) in cash. | Video

UPDATE 2-J&J makes $2.1 bln offer to buy out Japan cosmetics firm Ci:z

* Offer represents 55 pct premium over Tuesday's closing price

Select another date: